C75: A phase 2 study of technetium Tc 99m trofolastat chloride (MIP-1404) SPECT/CT to identify local disease and lymph node metastases in high-risk patients undergoing radical prostatectomy (RP) and extended pelvic lymph node dissection (ePLND) for prostate cancer (PCa): Analysis of imaging assessments with comparison to histopathology and MRI